HC directs Radha Soami Chief, others to pay Rs 6000 crore to Singh Brothers for settling Ranbaxy-Daichii dispute
New Delhi: The Delhi High Court has directed Radha Soami Satsang Beas (RSSB) Chief Gurinder Singh Dhillon, his family members and 55 other entities and individuals to pay Rs 6,373 crore dues to an erstwhile billionaire with Fortis Healthcare, Religare and Ranbaxy Laboratories- Singh brothers; so that the brothers can settle a decade long dispute related to Daiichi Sankyo’s acquisition of Ranbaxy Laboratories.
The dispute fumed after the Singh Brothers (Malvinder Mohan Singh and Shivinder Mohan Singh) were accused of suppressing critical information while selling their pharma firm Ranbaxy Laboratories to Daiichi. However, the non-disclosure of facts came to the front after the manufacturing plant faced severe regulatory issues with the US Food and Drug Administration.
Thereafter, a lawsuit was moved by with the Singapore arbitration tribunal that directed Singh brothers to pay Rs 2,562 crore to settle the dispute. The ex-Ranbaxy promoters challenged the tribunal’s decision before courts in India and Singapore, however, the Delhi HC upheld the award in January 2018.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.